Literature DB >> 12102627

Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors.

Dong Wang1, Michal Pechar, Weijie Li, Pavla Kopecková, Dieter Brömme, Jindrich Kopecek.   

Abstract

Cathepsin K is the major enzyme responsible for the degradation of the protein matrix of bone and probably for the destruction of articular cartilage in rheumatoid arthritis joints. These processes occur mainly in the resorption lacuna and within the lysosomal compartment. Here, we have designed, synthesized, and evaluated new lysosomotropic (water-soluble) polymer-cathepsin K inhibitor conjugates. In particular, we characterized the relationship between conjugate structures and their activity to inhibit cathepsins K, B, L, and papain. A potent selective cathepsin K inhibitor, 1,5-bis(N-benzyloxycarbonylleucyl)carbohydrazide, was modified to 1-(N-benzyloxycarbonylleucyl)-5-(phenylalanylleucyl)carbohydrazide (I) to facilitate polymer conjugation. It was conjugated to the polymer chain termini of two water-soluble polymers [alpha-methoxy poly(ethylene glycol), abbreviated as mPEG-I; semitelechelic poly[N-(2-hydroxypropyl)methacrylamide], abbreviated as ST-PHPMA-I]. The conjugation of inhibitor I to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer side chains was accomplished via either a Gly-Gly spacer (PHPMA-GG-I) or with no spacer between I and the copolymer backbone (PHPMA-I). Kinetic analysis revealed that free inhibitor I possessed an apparent second-order rate constant against cathepsin K (k(obs)/[I] = 1.3 x 10(6) M(-1) s(-1)) similar to that of unmodified 1,5-bis(Cbz-Leu) carbohydrazide, while I conjugated to the chain termini of mPEG and ST-PHPMA-COOH had slightly lower values (about 5 x 10(5) M(-1) s(-1)). The k(obs)/[I] values for I attached to the side chains of HPMA copolymers (PHPMA-GG-I and PHPMA-I) were about 3 x 10(4) M(-1) s(-1). When tested against cathepsin L, inhibitor I and all its polymer conjugates produced k(obs)/[I] values 1-2 orders of magnitude less than those determined for cathepsin K, while for cathepsin B and papain, the values were 2-4 orders of magnitude lower. The ability of mPEG-I and ST-PHPMA-I to inhibit cathepsin K activity in synovial fibroblasts was also evaluated. Both polymer-bound inhibitors were internalized by endocytosis and were ultimately trafficked to the lysosomal compartment. ST-PHPMA-I was internalized faster than mPEG-I. The inhibitory activity in the synovial fibroblast assay correlated with the rate of internalization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12102627     DOI: 10.1021/bi0257080

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

Review 1.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

Review 2.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

3.  Syntheses of click PEG-dexamethasone conjugates for the treatment of rheumatoid arthritis.

Authors:  Xin-Ming Liu; Ling-dong Quan; Jun Tian; Frederic C Laquer; Pawel Ciborowski; Dong Wang
Journal:  Biomacromolecules       Date:  2010-10-11       Impact factor: 6.988

4.  Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.

Authors:  Adele L Boskey; Bruce D Gelb; Eric Pourmand; Valery Kudrashov; Stephen B Doty; Lyudmila Spevak; Mitchell B Schaffler
Journal:  Calcif Tissue Int       Date:  2009-01-27       Impact factor: 4.333

5.  Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.

Authors:  Ludovic Gillet; Sébastien Roger; Pierre Besson; Fabien Lecaille; Jacques Gore; Philippe Bougnoux; Gilles Lalmanach; Jean-Yves Le Guennec
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

6.  Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice.

Authors:  Min Yang; Jiusong Sun; Tinghu Zhang; Jian Liu; Jie Zhang; Michael A Shi; Froogh Darakhshan; Michèle Guerre-Millo; Karine Clement; Bruce D Gelb; Gregory Dolgnov; Guo-Ping Shi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

7.  Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.

Authors:  Mark W Robinson; Ileana Corvo; Peter M Jones; Anthony M George; Matthew P Padula; Joyce To; Martin Cancela; Gabriel Rinaldi; Jose F Tort; Leda Roche; John P Dalton
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

8.  Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.

Authors:  Colin M Stack; Conor R Caffrey; Sheila M Donnelly; Amritha Seshaadri; Jonathan Lowther; Jose F Tort; Peter R Collins; Mark W Robinson; Weibo Xu; James H McKerrow; Charles S Craik; Sebastian R Geiger; Rachel Marion; Linda S Brinen; John P Dalton
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

9.  Stability in plasmas of various species of HPMA copolymer-PGE1 conjugates.

Authors:  Huaizhong Pan; Pavla Kopecková; Jihua Liu; Dong Wang; Scott C Miller; Jindrich Kopecek
Journal:  Pharm Res       Date:  2007-09-25       Impact factor: 4.200

10.  Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice.

Authors:  Xin Wei; Gang Zhao; Xiaobei Wang; Nagsen Gautam; Zhenshan Jia; Zhifeng Zhao; Dexuan Kong; Fan Zhang; Sushil Kumar; Yuanyuan Sun; Ningrong Chen; Xiaoyan Wang; Libin Yang; Rongguo Ren; Geoffrey M Thiele; Tatiana K Bronich; James R O'Dell; Yazen Alnouti; Dong Wang
Journal:  Nanomedicine       Date:  2020-07-15       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.